25.54

15.01% -4.50

Stoke Therapeutics Inc (STOK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$30.04

Offen:

$29.3

24-Stunden-Volumen:

1.89M

Relative Volume:

1.69

Marktkapitalisierung:

$1.40B

Einnahmen:

$199.89M

Nettoeinkommen (Verlust:

$52.48M

KGV:

30.05

EPS:

0.85

Netto-Cashflow:

$61.15M

1W Leistung:

-22.64%

1M Leistung:

-0.12%

6M Leistung:

+165.11%

1J Leistung:

+98.52%

1-Tages-Spanne:

$24.50

$29.44

1-Wochen-Bereich:

$24.50

$33.13

52-Wochen-Spanne:

$5.35

$38.69

Stoke Therapeutics Inc Stock (STOK) Company Profile

Firmenname

Stoke Therapeutics Inc

Sektor

Healthcare (1139)

Branche

Biotechnology (635)

Telefon

781-430-8200

Adresse

45 WIGGINS AVENUE, BEDFORD, MA

Mitarbeiter

128

Twitter

@stoketx

Nächster Verdiensttermin

2025-03-18

Neueste SEC-Einreichungen

STOK's Discussions on Twitter

Vergleichen Sie STOK mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
STOK Stoke Therapeutics Inc	25.51	1.65B	199.89M	52.48M	61.15M	0.85
VRTX Vertex Pharmaceuticals Inc	423.86	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	640.45	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	430.98	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	823.63	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.16	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Stoke Therapeutics Inc Stock (STOK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-18	Eingeleitet	Jefferies	Buy
2024-12-20	Eingeleitet	Chardan Capital Markets	Buy
2024-10-14	Fortgesetzt	Leerink Partners	Outperform
2024-03-26	Hochstufung	TD Cowen	Market Perform → Outperform
2023-11-20	Fortgesetzt	JP Morgan	Neutral
2023-07-25	Herabstufung	TD Cowen	Outperform → Market Perform
2023-05-01	Hochstufung	BofA Securities	Underperform → Neutral
2023-04-26	Fortgesetzt	Canaccord Genuity	Buy
2023-01-06	Herabstufung	BofA Securities	Buy → Underperform
2022-10-24	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-01-31	Eingeleitet	Jefferies	Buy
2021-12-03	Eingeleitet	BofA Securities	Buy
2021-11-22	Hochstufung	JP Morgan	Neutral → Overweight
2021-05-18	Eingeleitet	UBS	Neutral
2021-05-10	Hochstufung	Wedbush	Neutral → Outperform
2021-04-26	Fortgesetzt	Credit Suisse	Outperform
2021-02-10	Herabstufung	Wedbush	Outperform → Neutral
2020-12-15	Fortgesetzt	H.C. Wainwright	Buy
2020-12-11	Bestätigt	Needham	Buy
2020-10-23	Eingeleitet	Cantor Fitzgerald	Overweight
2020-09-29	Fortgesetzt	JP Morgan	Neutral
2020-09-29	Eingeleitet	Needham	Buy
2019-12-18	Eingeleitet	Wedbush	Outperform
2019-11-12	Eingeleitet	BTIG Research	Buy
2019-10-25	Eingeleitet	H.C. Wainwright	Buy
2019-07-15	Eingeleitet	Canaccord Genuity	Buy
2019-07-15	Eingeleitet	Cowen	Outperform
2019-07-15	Eingeleitet	Credit Suisse	Outperform
2019-07-15	Eingeleitet	JP Morgan	Overweight

Alle ansehen

Stoke Therapeutics Inc Aktie (STOK) Neueste Nachrichten

11:35 AM

Stoke Therapeutics (STOK): JP Morgan Raises Price Target, Mainta - GuruFocus

11:35 AM

09:14 AM

Live market analysis of Stoke Therapeutics Inc.Buy Signal & Stock Portfolio Risk Management - newser.com

09:14 AM

08:45 AM

Why Stoke Therapeutics Inc. stock attracts high net worth investorsQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - newser.com

08:45 AM

08:15 AM

Can Stoke Therapeutics Inc. stock sustain institutional interestMarket Activity Summary & Daily Momentum Trading Reports - newser.com

08:15 AM

05:17 AM

Using portfolio simulators with Stoke Therapeutics Inc. includedJuly 2025 Institutional & Safe Capital Investment Plans - newser.com

05:17 AM

04:46 AM

What technical models suggest about Stoke Therapeutics Inc.’s comebackJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com

04:46 AM

04:22 AM

What insider trading reveals about Stoke Therapeutics Inc. stockJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com

04:22 AM

12:51 PM

Will Stoke Therapeutics Inc. stock maintain momentum in 2025Market Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com

12:51 PM

Nov 02, 2025

Does Stoke Therapeutics Inc. show high probability of rebound2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com

Nov 02, 2025

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Nov 02, 2025

Nov 01, 2025

Stoke Therapeutics Shares Plunge Following Clinical Trial Data Release - AD HOC NEWS

Nov 01, 2025

Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 6.3%Should You Sell? - MarketBeat

Nov 01, 2025

Is Stoke Therapeutics Inc. stock a good choice for value investorsTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Stoke Therapeutics Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView

Oct 31, 2025

Exit strategy if you’re trapped in Stoke Therapeutics Inc.July 2025 Macro Moves & Weekly High Return Opportunities - newser.com

Oct 31, 2025

Oct 30, 2025